RNA
133 Employers in 223 locations
133 Employers in 223 locations
Employers working on RNA work in 102 other areas
Displaying 1 - 15 of 102 related areas- Therapeutics (22)
- Small Molecules (18)
- COVID-19 (17)
- RNAi (12)
- Cell and Gene Therapy (11)
- Vaccines (11)
- mRNA (8)
- Diagnostics (7)
- Drug Discovery (7)
- DNA (6)
- Drug Delivery (6)
- Antisense Oligonucletide (ASO) (5)
- Cancer (5)
- DNA Sequencing (5)
Displaying 1 - 60 of 133 employers
Only three business areas are listed for each employer.Business Area(s)
Description
858 Therapeutics is a biotechnology and drug discovery company developing a ...
Business Area(s)
Description
aceRNA Technologies Co., Ltd. is a biotech startup established in 2018 based on ...
Business Area(s)
Description
Develops RNA targeting technologies.
Business Area(s)
Description
The company makes biodegradable capsules that protect seeds. The capsules use ...
Business Area(s)
Description
AIM ImmunoTech Inc. focuses on researching and developing therapeutics to treat ...
Business Area(s)
Description
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the ...
Business Area(s)
Description
Alida Biosciences is an early-stage, VC backed startup in San Diego focused on ...
Business Area(s)
Description
Alida Biosciences (AlidaBio) is a biotechnology company focused on developing ...
Business Area(s)
Description
Alnylam develops innovative RNAi-based medicines in four therapeutic areas ...
Business Area(s)
Description
Altamira Therapeutics is developing OligoPhore™ / SemaPhore™ as a versatile ...
Business Area(s)
Description
Altogen Labs is a Good Laboratory Practice (GLP)-compliant CRO laboratory that ...
Business Area(s)
Description
Amaroq’s research team has discovered lncRNA molecules that are highly expressed ...
Business Area(s)
Description
AmRNA distributes RNA products and services to streamline access to RNA science ...
Business Area(s)
Description
Developing mRNA Lightning, a platform for the discovery of small molecule mRNA ...
Business Area(s)
Description
Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company ...
Business Area(s)
Description
ARQ Genetics offers custom-designed gene panels to provide accurate real-time ...
Business Area(s)
Description
Arrakis is developing small molecules that bind RNAs to prevent protein ...
Business Area(s)
Description
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by ...
Business Area(s)
Description
Ascidians – also known as sea squirts – are ocean creatures and primordial ...
Business Area(s)
Description
Developed a proprietary platform that holds the potential to discover novel ...
Business Area(s)
Description
Autonomous Therapeutics is developing Encrypted RNA™, a new class of RNA that ...
Business Area(s)
Description
Developed a proprietary platform for RNA structural biology that allows for the ...
Business Area(s)
Description
Basic Genomics AB is developing RNA biology tools, including synthetic long-read ...
Business Area(s)
Description
Beta Hatch farms high-protein insects for dogs, chickens, pigs, and fish, and ...
Business Area(s)
Description
Bio-Path Holdings is a an oncology-focused biotechnology company leveraging its ...
Business Area(s)
Description
BioEcho follows a completely new approach: based on the principle of reverse ...
Business Area(s)
Description
BioNTech was founded in 2008 on the understanding that every cancer patient’s ...
Business Area(s)
Description
Biosplice Therapeutics has produced fresh biological insights and unique ...
Description
Develops single molecule RNA measurement assays.
Business Area(s)
Description
Capsida is a biotechnology company that is developing a new class of targeted ...
Description
Capstan is combining the power of in vivo cell therapy with the precision of ...
Business Area(s)
Description
Developing of non-coding RNA-based therapeutics designed to address the root ...
Business Area(s)
Description
Chimeron Bio creates RNA therapeutics and vaccines.
Business Area(s)
Description
Circio Holding ASA is a biotechnology company developing novel circular RNA and ...
Business Area(s)
Description
Circular Genomics is a biotechnology and genomics company with a vision to use ...
Business Area(s)
Description
Codetta Biosciences is multi omics technology company developing a next ...
Business Area(s)
Description
Creyon Bio is taking an engineering approach to creating new oligonucleotide ...
Business Area(s)
Description
CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that ...
Business Area(s)
Description
DESTINA is a diagnostics company, offering innovative Nucleic Acid Testing and ...
Business Area(s)
Description
DiamiR develops and diagnostic technology based on analysis of brain-enriched ...
Business Area(s)
Description
DxTerity is a patient-centric genomics company bringing the power of real-world ...
Business Area(s)
Description
Develops Enhanced CrossLinking and Immunoprecipitation (eCLIP), followed by high ...
Business Area(s)
Description
enGene Inc. has developed a highly flexible nucleotide (DNA and RNAi) delivery ...
Business Area(s)
Description
eTheRNA immunotherapies is developing first in class mRNA immunotherapies for ...
Business Area(s)
Description
Ethris is paving a new path from genes to therapeutic proteins using our ...
Business Area(s)
Description
Orphan non-coding RNAs (oncRNAs) are only observed in cancer and diseased ...
Business Area(s)
Description
Expansion Therapeutics is a drug discovery and development company pursuing the ...
Business Area(s)
Description
Flamingo has a late-stage pipeline focused RNA-targeting antisense ...
Business Area(s)
Description
Developing RNA based liquid biopsy. Circulating RNA analysis have the potential ...
Business Area(s)
Description
Develops SILVER-Seq™ ( Small Input Liquid Volume Extracellular RNA Sequencing) ...
Business Area(s)
Description
Developing diagnostics that measure stool-derived eukaryotic RNA (seRNA) to ...
Business Area(s)
Description
CAMBRIDGE, Mass., VANCOUVER, British Columbia, and BASEL, Switzerland, April 11 ...
Business Area(s)
Description
Developing RNAi therapies for Cardiovascular and Cardiometabolic disease